Abstract
The family history of cancer in children treated for a solid malignant tumour in the Paediatric Oncology Department at Institute Gustave-Roussy, has been investigated. In order to determine the role of germline p53 mutations in genetic predisposition to childhood cancer, germline p53 mutations were sought in individuals with at least one relative (first- or second-degree relative or first cousin) affected by any cancer before 46 years of age, or affected by multiple cancers. Screening for germline p53 mutation was possible in 268 index cases among individuals fulfilling selection criteria. Seventeen (6.3%) mutations were identified, of which 13 were inherited and four were de novo. Using maximum likelihood methods that incorporate retrospective family data and correct for ascertainment bias, the lifetime risk of cancer for mutation carriers was estimated to be 73% for males and nearly 100% for females with a high risk of breast cancer accounting for the difference. The risk of cancer associated with such mutations is very high and no evidence of low penetrance mutation was found. These mutations are frequently inherited but de novo mutations are not rare.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Morris Jones PH, Binchy A, Crowther D, Craft AW, Eden OB, Evans DGR, Thompson E, Mann JR, Martin J, Mitchell ELD and Santibáñez-Koref MF (1994) Prevalence and diversity of constitutional mutations in the p53gene among 21 Li–Fraumeni families. Cancer Res 54: 1298–1304
Brugières L, Gardes M, Moutou C, Chompret A, Meresse V, Martin A, Poisson N, Flamant F, Bonaïti-Pellié C, Lemerle J and Feunteun J (1993) Screening for germ line p53mutations in children with malignant tumors and a family history of cancer. Cancer Res 53: 452–455
Eeles RA (1995) Germline mutations in the TP53 gene. Cancer Surv 25: 101–124
Eeles RA, Warren W, Knee G, Bartek J, Averill D, Stratton MR and Blake PR (1993) Constitutional mutation in exon 8 of the p53gene in a patient with multiple primary tumors: molecular and immunohistochemical findings. Oncogene 8: 1269–1279
Felix CA, Strauss EA, D’Amico D, Tsokos M, Winter S, Mitsudomi T, Nau MM, Brown DL, Leahey AM, Horowitz ME, Poplack DG, Costin D and Minna JD (1993) A novel germline p53splicing mutation in a pediatric patient with a second malignant neoplasm. Oncogene 8: 1203–1210
Flaman J-M, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino A-P, Limacher J-M, Bron L, Benhattar J, Tada M, Van Meir EG, Estreicher A and Iggo RD (1995) A simple p53functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 92: 3963–3967
Frebourg T, Barbier N, Yan Y, Garber JE, Dreyfus M, Fraumeni J, Jr Li FP and Friend SH (1995) Germline p53mutations in 15 families with Li–Fraumeni syndrome. Am J Hum Genet 56: 608–615
Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni JF Jr and Li FP (1991) Follow-up study of 24 families with Li–Fraumeni syndrome. Cancer Res 51: 6094–6097
Gutiérrez MI, Bhatia KG, Barreiro C, Spangler G, Schvartzmann E, Muriel FS and Magrath IT (1994) A de novo p53germline mutation affecting codon 151 in a six year old child with multiple tumors. Hum Mol Genet 3: 2247–2248
Ishioka C, Frebourg T, Yan Y-X, Vidal M, Friend SH, Schmidt S and Iggo R (1993) Screening patients for heterozygous p53mutations using a functional assay in yeast. Nat Genet 5: 124–129
Jolly KW, Malkin D, Douglass EC, Brown TF, Sinclair AE and Look TA (1994) Splice-site mutation of the p53gene in a family with hereditary breast-ovarian cancer. Oncogene 9: 97–102
Knudson AG Jr (1971) Mutation and cancer. Statistical analysis of retinoblastoma. Proc Natl Acad Sci USA 68: 820–823
Kony SJ, De Vathaire F, Chompret A, Shamsaldim A, Grimaud E, Raquin M-A, Oberlin O, Brugières L, Feunteun J, Eschwège F, Chavaudra J, Lemerle J and Bonaiti-Pellié C (1997) Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 350: 91–95
Le Bihan C and Bonaïti-Pellié C (1994) A method for estimating cancer risk in p53mutation carriers. Cancer Detect Prev 18: 171–178
Le Bihan C, Moutou C, Brugières L, Feunteun J and Bonaïti-Pellié C (1995) Arcad: a method for estimating age-dependent disease risk associated with mutation carrier status from family data. Genet Epidemiol 12: 13–25
Li FP, Fraumeni JF, Jr Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA and Miller RW (1988) A cancer family syndrome in 24 kindreds. Cancer Res 48: 5358–5362
Lomax ME, Barnes DM, Gilchrist R, Picksley SM, Varley JM and Camplejohn RS (1997) Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53in a Li–Fraumeni like family. Oncogene 14: 1869–1874
Lustbader ED, Williams WR, Bondy ML, Strom S and Strong LC (1992) Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients. Am J Hum Genet 51: 344–356
Malkin D (1994) p53and the Li–Fraumeni syndrome. Biochim Biophys Acta Rev Cancer 1198: 197–213
Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Borresen A-L, Li FP, Garber J and Strong LC (1992) Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 326: 1309–1315
Mclntyre JF, Smith-Sorensen B, Friend SH, Kassell J, Borresen A-L, Yan YX, Russo C, Sato J, Barbier N, Miser J, Malkin D and Gebhardt MC (1994) Germline mutations of the p53tumor suppressor gene in children with osteosarcoma. J Clin Oncol 12: 925–930
Scott RJ, Krummenacher F, Mary J-L, Weber W, Spycher M and Müller H (1993) Inheritable p53mutation in a patient with multiple cancer and its significance for genetic counselling. Schweiz Med Wochenschr 123: 1287–1292
Speiser P, Gharehbaghi-Schnell E, Eder S, Haid A, Kovarik J, Nenutil R, Sauter G, Schneeberger CH, Vojtesek B, Wiltschke CH and Zeillinger R (1996) A constitutional de novo mutation in exon 8 of the p53gene in a patient with multiple primary malignancies. Br J Cancer 74: 269–273
Strong L, Williams W and Tainsky MA (1992) The Li–Fraumeni syndrome: from clinical epidemiology to molecular genetics. Am J Epidemiol 135: 190–199
Toguchida J, Yamaguchi T, Dayton SH, Beauchamp RL, Herrera GE, Ishizaki K, Yamamuro T, Meyers PA, Little JB, Sasaki MS, Weichselbaum RR and Yandell DW (1992) Prevalence and spectrum of germline mutations of the p53gene among patients with sarcoma. N Engl J Med 326: 1301–1308
Varley JM, McGown G, Thorncroft M, Cochrane S, Morrison P, Woll P, Kelsey AM, Mitchell ELD, Boyle J, Birch JM and Evans DGR (1996) A previously undescribed mutation within the tetramerisation domain of TP53in a family with Li–Fraumeni syndrome. Oncogene 12: 2437–2442
Varley JM, Evans DGR and Birch JM 1997 b) Li–Fraumeni syndrome: a molecular and clinical review. Br J Cancer 76: 1–14
Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DGR and Birch JM 1997 a) Germ-line mutations of TP53in Li–Fraumeni families: an extended study of 39 families. Cancer Res 57: 3245–3252
Varley JM, McGown G, Thorncroft M, James LA, Margison GP, Forster G, Evans DG, Harris M, Kelsey AM and Birch JM (1999) Are there low-penetrance TP53alleles? Evidence from childhood adrenocortical tumors. Am J Hum Genet 65: 995–1006
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Chompret, A., Brugières, L., Ronsin, M. et al. P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer 82, 1932–1937 (2000). https://doi.org/10.1054/bjoc.2000.1167
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1167
Keywords
This article is cited by
-
First case of endometrial cancer after yolk sac tumor in a patient with Li-Fraumeni syndrome
BMC Women's Health (2023)
-
Li-Fraumeni-Syndrom
Die Radiologie (2022)
-
Novel PHOX2B germline mutation in childhood medulloblastoma: a case report
Hereditary Cancer in Clinical Practice (2021)
-
A first report of a rare TP53 variant associated with Li-Fraumeni syndrome manifesting as invasive breast cancer and malignant solitary fibrous tumor
World Journal of Surgical Oncology (2021)
-
Germline risk of clonal haematopoiesis
Nature Reviews Genetics (2021)